Researcher profile · Semantic Scholar

N. Alexander

h-index: 8
Works: 20
Citations: 320

Most-cited papers

Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis.
A. McEvoy, K. Lachance, D. Hippe, Kelsey Cahill +11 more
2022JAMA dermatology110 citations Open access
Semantic Scholar
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study
Shenmin Zhang, K. Tang, G. Wan, N. Nguyen +21 more
2023Journal of American Academy of Dermatology54 citations Open access
Semantic Scholar
Prediction of early-stage melanoma recurrence using clinical and histopathologic features
G. Wan, N. Nguyen, Feng Liu, Mia S. DeSimone +24 more
2022npj Precision Oncology46 citations Open access
Semantic Scholar
Clinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patients
Neha Singh, N. Alexander, K. Lachance, C. Lewis +7 more
2020Journal of American Academy of Dermatology42 citations Open access
Semantic Scholar
Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study
G. Wan, Sara Khattab, B. Leung, Shi-Jia Zhang +18 more
2024British Journal of Dermatology13 citations Open access
Semantic Scholar
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study
Shi-Jia Zhang, K. Tang, G. Wan, N. Nguyen +21 more
2023medRxiv12 citations Open access
Semantic Scholar
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy
N. Nguyen, G. Wan, P. Ugwu-Dike, N. Alexander +29 more
2023Journal of American Academy of Dermatology12 citations Open access
Semantic Scholar
Alopecia areata after mogamulizumab treatment
N. Raval, N. Alexander, Karlee De Monnin, C. C. Yokoyama +3 more
2021JAAD Case Reports12 citations Open access
Semantic Scholar
Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort Study
G. Wan, N. Nguyen, B. Leung, H. Rashdan +16 more
2023Journal of American Academy of Dermatology5 citations Open access
Semantic Scholar
Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade
L. Tachiki, Y. Moshiri, D. Hippe, Emily Gong +16 more
2025Journal for ImmunoTherapy of Cancer4 citations Open access
Semantic Scholar
Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients
Song Y Park, C. Church, N. Alexander, M. Shinohara +4 more
2020JAAD Case Reports4 citations Open access
Semantic Scholar
658 Clinical and histopathologic risk factors for early-stage melanoma recurrence
B. Leung, N. Nguyen, M. S. Choi, M. DeSimone +16 more
2022Journal of Investigative Dermatology3 citations Open access
Semantic Scholar
Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort Study
G. Wan, N. Nguyen, B. Leung, H. Rashdan +16 more
2023medRxiv1 citations Open access
Semantic Scholar
292 Is it safe to discontinue immunotherapy after a response in merkel cell carcinoma?
L. Tachiki, L. Zawacki, D. Hippe, Y. Moshiri +7 more
2022Journal of Investigative Dermatology1 citations Open access
Semantic Scholar
Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy
L. Tachiki, L. Zawacki, D. Hippe, Y. Moshiri +7 more
2022Journal of Investigative Dermatology1 citations Open access
Semantic Scholar
865 Immunotherapy in advanced Merkel cell carcinoma: Frequent responses but a potentially concerning recurrence rate after therapy discontinuation
Y. Moshiri, N. Alexander, T. Akaike, C. Doolittle-Amieva +3 more
20201 citations Open access
Semantic Scholar
554 Clinical outcomes of patients treated with immune checkpoint inhibitor therapy for early-stage melanoma recurrence: a retrospective cohort study
N. Nguyen, G. Wan, H. Rashdan, B. Leung +11 more
2023Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
568 Pre-existing immune-mediated disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study
G. Wan, N. Nguyen, B. Leung, H. Rashdan +15 more
2023Journal of Investigative Dermatology0 citations Open access
Semantic Scholar
215 Cutaneous immune-related adverse events predict longer patient survival in advanced cancer patients
C. Lu, S. Zhang, K. Tang, P. Ugwu-Dike +21 more
2022Journal of Investigative Dermatology0 citations Open access
Semantic Scholar
578 Addressing the missing components for appropriate surveillance of Merkel cell carcinoma patients: Detailed recurrence data and an integrated risk analysis approach
A. McEvoy, K. Lachance, D. Hippe, N. Singh +7 more
2019Journal of Investigative Dermatology0 citations Open access
Semantic Scholar

S. Kwatra

×9

G. Wan×8

N. Nguyen×8

P. Nghiem×7

P. Ugwu-Dike×7

N. Raval×6

Y. Semenov×6

M. Amadife×6